1-3 of 3
Lilj Uziel, MD
Close
Sort by
Journal Articles

Combined Fludarabine, Cyclophosphamide, and Alemtuzumab (FCC), an Active Regimen for Treated Patients with Chronic Lymphocytic Leukemia (CLL).

Marco Montillo, MD, Sara Miqueleiz, MD, Alessandra Tedeschi, MD, Francesca Ricci, MD, Eleonora Vismara, MD, Denis Ciapanna, MD, Valeria Belsito Petrizzi, MD, Monica Crugnola, MD, Mauro Spriano, MD, Lilj Uziel, MD, Angelo De Blasio, MD, Pierangelo Spedini, PhD, Enrica Morra, MD
Journal: Blood
Blood (2007) 110 (11): 3133.
https://doi.org/10.1182/blood.V110.11.3133.3133
Published: 2007
Journal Articles

Low Efficacy of Thalidomide in Improving Response after Induction in Myeloma Patients Candidate to High-Dose Therapy.

Alessandro Corso, MD, Silvia Mangiacavalli, MD, Luciana Barbarano, MD, Patrizia Zappasodi, MD, Luciano Banfi, MD, Luigi Montalbetti, MD, Antonio Mazzone, MD, Sergio Fava, MD, Guido Frigerio, MD, Luciano Isa, MD, Sergio Montanara, MD, Daniele Perego, MD, Maria SavareĢ€, MD, Lilj Uziel, MD, Alessandro Vismara, MD, Leonardo Campiotti, MD, Mario FiumanoĢ€, MD, Mario Lazzarino, MD, Enrica Morra, MD
Journal: Blood
Blood (2006) 108 (11): 3567.
https://doi.org/10.1182/blood.V108.11.3567.3567
Published: 2006
Journal Articles

Unexpectedly High Incidence of Interstitial Pneumonia in Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Rituximab-CHOP-14 Supported with Pegfilgrastim.

Ercole Brusamolino, MD, Chiara Rusconi, MD, Luigi Montalbetti, MD, Livio Gargantini, MD, Graziella Pinotti, MD, Lilj Uziel, MD, Sergio Fava, MD, Luigi Rigacci, MD, Guido Pagnucco, MD, Guido Frigerio, MD, Mario Fiumano, MD, Luciano Banfi, MD, Francesco Rodeghiero, MD, Giovanni Ucci, MD, Alberto De Paoli, MD, Giuseppe Attardo Parrinello, MD, Enrica Morra, MD, Mario Lazzarino, MD
Journal: Blood
Blood (2005) 106 (11): 3330.
https://doi.org/10.1182/blood.V106.11.3330.3330
Published: 2005